RNS Number : 1928N

Societe Generale SA

28 January 2021

Ap19

FORM 8.3

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1.       KEY INFORMATION

Name of person dealing (Note 1)	Société Générale S.A.
Company dealt in	Willis Towers Watson plc
Class of relevant security to which the dealings being disclosed relate (Note 2)	US$0.000304635 ordinary shares
Date of dealing	27/01/2021

2.         INTERESTS AND SHORT POSITIONS

(a)        Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

	Long		Short
	Number	(%)	Number	(%)
(1) Relevant securities	766,027	0.59	4,916	0.00
(2) Derivatives (other than options)	1,408	0.00	8,131	0.01
(3) Options and agreements to purchase/sell	0	0.00	0	0.00
Total	*1,304,957	*1.01	13,047	0.01

* Include the holding of 537,522 shares on borrow products

(b)        Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security:	Long		Short
	Number	(%)	Number	(%)
(1) Relevant securities
(2) Derivatives (other than options)
(3) Options and agreements to purchase/sell
Total

Ap20

1.       DEALINGS (Note 4)

(a)      Purchases and sales

Purchase/sale	Number of relevant securities	Price per unit USD (Note 5)
Purchase	18	205.95
Purchase	32	208.08
Purchase	18	206.02
Purchase	16	208.59
Purchase	29	207.81
Purchase	16	208.13
Purchase	100	205.99
Purchase	7	207.81
Purchase	14	207.89
Purchase	13	207.92
Purchase	37	205.97
Purchase	5	207.54
Purchase	100	205.61
Purchase	50	208.52
Sale	100	205.97
Sale	92	205.88
Sale	5	205.79
Sale	73	205.79
Sale	17	205.78
Sale	25	205.79
Sale	70	205.78
Sale	17	205.79
Sale	14	204.22
Sale	25	207.36
Sale	28	209.02
Sale	29	207.31
Sale	16	205.89
Sale	16	205.89
Sale	17	205.83
Sale	13	208.68
Sale	30	207.9
Sale	15	204.32
Sale	16	205.76
Sale	15	207.78
Sale	15	207
Sale	255	205.97
Sale	1	207.54
Sale	75	205.71
Sale	100	205.71
Sale	9	205.71
Sale	138	205.8
Sale	46	205.68
Sale	46	205.68
Sale	115	205.79
Sale	46	205.64
Sale	115	207.54
Sale	191	207.54
Sale	38	207.54
Sale	173	207.54
Sale	24	207.54
Sale	888	205.97
Sale	1,976	205.97
Purchase/sale	Number of relevant securities	Price per unit EUR (Note 5)
Sale	58	171
Total Purchases	455
Total Sales	4,942

(b)      Derivatives transactions (other than options transactions)

Product name, e.g. CFD Nature of transaction (Note 6) Number of relevant securities (Note 7) Price per unit USD (Note 5)

(c)      Options transactions in respect of existing relevant securities

(i)       Writing, selling, purchasing or varying

Product name, e.g. call option Writing, selling, purchasing, varying etc. Number of securities to which the option relates (Note 7) Exercise price Type, e.g. American, European etc. Expiry date Option money paid/received per unit (Note 5)

(ii)      Exercising

Product name, e.g. call option Number of securities Exercise price per unit (Note 5)

(d)      Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction (Note 8) Details Price per unit (if applicable) (Note 5)

Ap21

2.       OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any 

other person relating to the voting rights of any relevant securities under any optionreferred to on this 

form or relating to the voting rights or future acquisition or disposal of any relevant securities to which 

any derivative referred to on this form is referenced. If none, this should be stated.

Is a Supplemental Form 8 attached? (Note 9)                                            No

Date of disclosure	28/01/2021
Contact name	Société Générale - Disclosure team
Telephone number	+33 1 42 14 92 74
If a connected EFM, name of offeree/offeror with which connected
If a connected EFM, state nature of connection (Note 10)

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

ISEVVLBLFFLXBBQ